Minimal Cross-resistance to Tenofovir in Children and Adolescents Failing ART Makes Them Eligible for Tenofovir-Lamivudine-Dolutegravir Treatment

Fixed-dose combination of dolutegravir (DTG) with tenofovir disoproxil fumarate (TDF) and lamivudine (3TC) likely improves adherence and has a favorable resistance profile. We evaluated predicted efficacy of TLD (TDF-3TC-DTG) in children and adolescents failing abacavir (ABC), zidovudine (AZT), or T...

Descripción completa

Detalles Bibliográficos
Autores principales: Steegen, Kim, Levin, Leon, Evans, Denise, Technau, Karl-Günter, Hans, Lucia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
HIV Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9508940/
https://www.ncbi.nlm.nih.gov/pubmed/35895893
http://dx.doi.org/10.1097/INF.0000000000003647

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9508940/
https://www.ncbi.nlm.nih.gov/pubmed/35895893
http://dx.doi.org/10.1097/INF.0000000000003647

Ejemplares similares